Nature versus Nurture: Death of a dogma, and the road ahead

Neuron

Volumn 68, Issue 2, 2010, Pages 196-200

  Traynor, Bryan J ^a   Singleton, Andrew B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALOSIN CONTAINING PROTEIN;

ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; LIFESPAN; LIFESTYLE; MEDICAL RESEARCH; MYOPATHY; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; DISEASE; ENVIRONMENT; GENETIC PREDISPOSITION; GENOME; HEALTH CARE DELIVERY; PHARMACOGENETICS; TRENDS;

DELIVERY OF HEALTH CARE; DISEASE; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENOME; HUMANS; PHARMACOGENETICS; RISK FACTORS;

EID: 77957898466     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2010.10.002     Document Type: Review

References (45)

1. Akesson A., Weismayer C., Newby P.K., Wolk A. Combined effect of low-risk dietary and lifestyle behaviors in primary prevention of myocardial infarction in women. Arch. Intern. Med. 2007, 167:2122-2127.
2. Bjornsson H.T., Fallin M.D., Feinberg A.P. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 2004, 20:350-358.
3. Burgner D., Jamieson S.E., Blackwell J.M. Genetic susceptibility to infectious diseases: Big is beautiful, but will bigger be even better?. Lancet Infect. Dis. 2006, 6:653-663.
4. Carr G. Special Report: The Human Genome: Biology 2.0. The Economist 2010, 395:50.
5. Cavelaars A.E., Kunst A.E., Geurts J.J., Crialesi R., Grötvedt L., Helmert U., Lahelma E., Lundberg O., Mielck A., Rasmussen N.K., et al. Persistent variations in average height between countries and between socio-economic groups: An overview of 10 European countries. Ann. Hum. Biol. 2000, 27:407-421.
6. Corella D., Ordovas J.M. Integration of environment and disease into 'omics' analysis. Curr. Opin. Mol. Ther. 2005, 7:569-576.
7. Crawford F.C., Wood M., Ferguson S., Mathura V.S., Faza B., Wilson S., Fan T., O'Steen B., Ait-Ghezala G., Hayes R., Mullan M.J. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw). Brain Res. 2007, 1185:45-58.
8. Doll R., Hill A.B. Smoking and carcinoma of the lung; preliminary report. BMJ 1950, 2:739-748.
9. Gerra G., Garofano L., Zaimovic A., Moi G., Branchi B., Bussandri M., Brambilla F., Donnini C. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2005, 135B:73-78.
10. Gibbs J.R., van der Brug M.P., Hernandez D.G., Traynor B.J., Nalls M.A., Lai S.L., Arepalli S., Dillman A., Rafferty I.P., Troncoso J., et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010, 6. e1000952.
11. Gudbjartsson D.F., Walters G.B., Thorleifsson G., Stefansson H., Halldorsson B.V., Zusmanovich P., Sulem P., Thorlacius S., Gylfason A., Steinberg S., et al. Many sequence variants affecting diversity of adult human height. Nat. Genet. 2008, 40:609-615.
12. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 2010, 42:781-785.
13. Hedbäck B., Perk J., Wodlin P. Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme. Eur. Heart J. 1993, 14:831-835.
14. Ilyin S.E., Belkowski S.M., Plata-Salamán C.R. Biomarker discovery and validation: Technologies and integrative approaches. Trends Biotechnol. 2004, 22:411-416.
15. Khoury M.J., Davis R., Gwinn M., Lindegren M.L., Yoon P. Do we need genomic research for the prevention of common diseases with environmental causes?. Am. J. Epidemiol. 2005, 161:799-805.
16. Kolonel L.N., Altshuler D., Henderson B.E. The multiethnic cohort study: Exploring genes, lifestyle and cancer risk. Nat. Rev. Cancer 2004, 4:519-527.
17. Kremer I., Bachner-Melman R., Reshef A., Broude L., Nemanov L., Gritsenko I., Heresco-Levy U., Elizur Y., Ebstein R.P. Association of the serotonin transporter gene with smoking behavior. Am. J. Psychiatry 2005, 162:924-930.
18. Krischek B., Inoue I. The genetics of intracranial aneurysms. J. Hum. Genet. 2006, 51:587-594.
19. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
20. Retraction-Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 2010, 375:445. Lancet.
21. Lettre G., Jackson A.U., Gieger C., Schumacher F.R., Berndt S.I., Sanna S., Eyheramendy S., Voight B.F., Butler J.L., Guiducci C., et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat. Genet. 2008, 40:584-591. Diabetes Genetics Initiative, FUSIONFUSION, KORAKORA, Prostate, Lung Colorectal and Ovarian Cancer Screening TrialProstate, Lung Colorectal and Ovarian Cancer Screening Trial, Nurses' Health StudyNurses' Health Study, SardiNIASardiNIA.
22. Levin B.E. Synergy of nature and nurture in the development of childhood obesity. Int. J. Obes. (Lond). 2009, 33(Suppl 1):S53-S56.
23. Meijer W.A., van Boxtel M.P., Van Gerven P.W., van Hooren S.A., Jolles J. Interaction effects of education and health status on cognitive change: A 6-year follow-up of the Maastricht Aging Study. Aging Ment. Health 2009, 13:521-529.
24. Murphy P.M. Molecular mimicry and the generation of host defense protein diversity. Cell 1993, 72:823-826.
25. Parchi P., Castellani R., Capellari S., Ghetti B., Young K., Chen S.G., Farlow M., Dickson D.W., Sima A.A., Trojanowski J.Q., et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 1996, 39:767-778.
26. Psaltopoulou T., Ilias I., Alevizaki M. The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: A review of meta-analyses. Rev. Diabet. Stud. 2010, 7:26-35.
27. Rutter M. The interplay of nature, nurture, and developmental influences: The challenge ahead for mental health. Arch. Gen. Psychiatry 2002, 59:996-1000.
28. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
29. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840. CHARGE Consortium, GERAD1 ConsortiumGERAD1 Consortium, EADI1 ConsortiumEADI1 Consortium.
30. Simón-Sánchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
31. Singleton A.B., Hardy J., Traynor B.J., Houlden H. Towards a complete resolution of the genetic architecture of disease. Trends Genet. 2010, 26:438-442.
32. Steckel R.H. Historical perspective on the standard of living using antropometric data. What Has Happened to the Quality of Life in the Advanced Industrialized Nations? 2004, 257-274. Edward Elgar Publishing, Northampton, MA. E.N. Wolff (Ed.).
33. Thacker E.L., Chen H., Patel A.V., McCullough M.L., Calle E.E., Thun M.J., Schwarzschild M.A., Ascherio A. Recreational physical activity and risk of Parkinson's disease. Mov. Disord. 2008, 23:69-74.
34. Traynor B.J. The era of genomic epidemiology. Neuroepidemiology 2009, 33:276-279.
35. van der Zee J., Pirici D., Van Langenhove T., Engelborghs S., Vandenberghe R., Hoffmann M., Pusswald G., Van den Broeck M., Peeters K., Mattheijssens M., et al. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology 2009, 73:626-632.
36. Visscher P.M., Hill W.G., Wray N.R. Heritability in the genomics era-concepts and misconceptions. Nat. Rev. Genet. 2008, 9:255-266.
37. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004, 36:377-381.
38. Weedon M.N., Lango H., Lindgren C.M., Wallace C., Evans D.M., Mangino M., Freathy R.M., Perry J.R., Stevens S., Hall A.S., et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat. Genet. 2008, 40:575-583. Diabetes Genetics Initiative, Wellcome Trust Case Control ConsortiumWellcome Trust Case Control Consortium, Cambridge GEM ConsortiumCambridge GEM Consortium.
39. Wermter A.K., Laucht M., Schimmelmann B.G., Banaschweski T., Sonuga-Barke E.J., Rietschel M., Becker K. From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders. Eur. Child Adolesc. Psychiatry 2010, 19:199-210.
40. Wexler N.S., Lorimer J., Porter J., Gomez F., Moskowitz C., Shackell E., Marder K., Penchaszadeh G., Roberts S.A., Gayán J., et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl. Acad. Sci. USA 2004, 101:3498-3503. U.S.-Venezuela Collaborative Research Project.
41. Wild C.P. Complementing the genome with an "exposome": The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1847-1850.
42. Willett W.C. Balancing life-style and genomics research for disease prevention. Science 2002, 296:695-698.
43. Williamson D.F., Vinicor F., Bowman B.A. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: Implications for health policy. Ann. Intern. Med. 2004, 140:951-957. Centers For Disease Control And Prevention Primary Prevention Working Group.
44. Wilson R.S., Mendes De Leon C.F., Barnes L.L., Schneider J.A., Bienias J.L., Evans D.A., Bennett D.A. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 2002, 287:742-748.
45. Yeh R.W., Sidney S., Chandra M., Sorel M., Selby J.V., Go A.S. Population trends in the incidence and outcomes of acute myocardial infarction. N. Engl. J. Med. 2010, 362:2155-2165.